The impact of DNA methylation technologies on drug toxicology
- 11 February 2014
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 10 (5), 637-646
- https://doi.org/10.1517/17425255.2014.889682
Abstract
Drug toxicology is central to drug development. Despite improvements in our understanding of molecular and cell biology, high attrition rates in drug development continue, speaking to the difficulties of developing unequivocal methods to predict the efficacy and safety of drugs.Keywords
This publication has 78 references indexed in Scilit:
- Exploring the cancer genome in the era of next-generation sequencingFrontiers of Medicine, 2012
- Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st centuryAltex, 2011
- Why animal studies are often poor predictors of human reactions to exposureJournal of the Royal Society of Medicine, 2009
- Animal experiments scrutinised: Systematic reviews demonstrate poor human clinical and toxicological utilityAltex, 2007
- Future of ToxicologyMechanisms of Toxicity and Drug Safety: Where Do We Go from Here?Chemical Research in Toxicology, 2006
- Recent advances in array comparative genomic hybridization technologies and their applications in human geneticsEuropean Journal of Human Genetics, 2005
- Application of genomics to toxicology research.Environmental Health Perspectives, 2002
- Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology, 2000
- European Researchers Grapple With Animal RightsScience, 1999
- Detecting Adverse Reactions to DrugsHuman Toxicology, 1988